Impact of allele‐specific peptides in proteome quantification
PROTEOMICS - CLINICAL APPLICATIONS2015Vol. 9(3-4), pp. 432–436
Citations Over Time
Abstract
MS-based proteome technologies have greatly improved our ability to detect and quantify proteomes across various biological samples. High throughput bottom-up proteome profiling in combination with targeted MS method, e.g. SRM assay, is emerging as a powerful approach in the field of biomarker discovery. In the past few years, increasing number of studies have attempted to integrate genomic and proteomic data for biomarker discovery. Here, we describe how allele-specific peptide can be applied in biomarker discovery and their impact in protein quantification.
Related Papers
- → A high-stringency blueprint of the human proteome(2020)215 cited
- → Cancer proteome-expression database: Genome Medicine Database of Japan Proteomics(2010)13 cited
- → The human eye proteome project(2013)9 cited
- → Human Proteome Project and Current Bioinformatics Status in Disease Diagnosis and Treatment(2018)1 cited
- → Mouse models for neurodegenerative diseases and a theory of proteomics(2003)